“One of the concerns is that diabetes in the western region is actually higher than the average in Jamaica. Whereas I ...

Diabetic retinopathy is a severe complication of diabetes that can lead to blindness. The Japanese clinical practice ...

As the world prepares for a “diabetes tsunami,” eye care experts believe AI could be key to saving health systems money.

The introduction of anti-VEGF agents has revolutionized the field of medical retina care by reducing rates of vision loss and ...

Nayanamritham 2.0 expands its scope to include screening for two major chronic eye diseases—glaucoma and age-related macular ...

The Government of Kerala, in collaboration with Remidio, a leader in AI-driven ophthalmic screening solutions, has launched ...

Semaglutide — the active ingredient in the brand-name meds Ozempic, Wegovy, and Rybelsus — treats type 2 diabetes and obesity ...

So far, five biosimilars that reference Eylea 2 mg have been approved by the FDA. Alvotech/Teva expect to regulatory approval ...

Aharon, Ph.D., Co-Founder & CEO of AEYE Health, in conversation with Jake Laznik, Senior Breaking News Desk Manager, The ...

JAX researchers used mice with nine different genetic backgrounds to identify factors influencing eye aging, paving the way for eye-based diagnostics for neurodegenerative diseases ...

Teva Pharmaceutical Industries and partner Alvotech said the Food and Drug Administration agreed to review their AVTO6 ...

AI has demonstrated remarkable proficiency in diagnosing various eye diseases, including diabetic retinopathy, glaucoma, and ...